about
Antitumor activity of pan-HER inhibitors in HER2-positive gastric cancer.Therapeutic strategies for afatinib-resistant lung cancer harboring HER2 alterations.Combined inhibition of MEK and PI3K pathways overcomes acquired resistance to EGFR-TKIs in non-small cell lung cancerComparative mutational evaluation of multiple lung cancers by multiplex oncogene mutation analysisYES1 activation induces acquired resistance to neratinib in HER2-amplified breast and lung cancersAcquired resistance mechanisms to afatinib in HER2-amplified gastric cancer cells
P50
description
researcher
@en
wetenschapper
@nl
name
Shinichi Toyooka
@en
Shinichi Toyooka
@nl
type
label
Shinichi Toyooka
@en
Shinichi Toyooka
@nl
prefLabel
Shinichi Toyooka
@en
Shinichi Toyooka
@nl
P31
P496
0000-0002-7588-6745